Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by pericles1on Sep 23, 2010 6:13pm

468 Views

Post# 17486117

RE: RE: RE: RE: I have been watching this Company

In my opinion it's an incremental advance and in first line with chemo I think it will cure a higher percentage than just chemo and that's what is important.

Even if it's only in Squamous cell types which I am very positive on we can still make a lot of money in this stock. How much I'll leave up to Gemini, but a lot. By the way where is Gemini, he must be on a desert island to not be posting during this activity. Us manipulators must be kept in line, ha!

Bullboard Posts

AI companies to invest in